Barclays’s Innovator US Equity Accelerated Plus ETF October XTOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16K Sell
494
-300
-38% -$10K ﹤0.01% 4620
2025
Q4
$26.6K Sell
794
-3,742
-82% -$123K ﹤0.01% 4839
2025
Q3
$148K Sell
4,536
-215
-5% -$6.9K ﹤0.01% 4484
2025
Q2
$149K Sell
4,751
-311
-6% -$9.04K ﹤0.01% 4431
2025
Q1
$144K Buy
5,062
+4,582
+955% +$135K ﹤0.01% 4244
2024
Q4
$14.1K Sell
480
-1,320
-73% -$38.7K ﹤0.01% 4961
2024
Q3
$51.7K Buy
+1,800
New +$51.3K ﹤0.01% 4739

Other funds holding XTOC

Barclays's XTOC Position: Q1 2026 in Review

Barclays reduced its Innovator US Equity Accelerated Plus ETF October (XTOC) stake by 38% in Q1 2026, selling an estimated $10K and leaving 494 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #4620.

Barclays first reported a position in XTOC in Q3 2024 and has held it in 7 quarters since. The position peaked at $149K in Q2 2025. 20 funds tracked by Wall St. Rank hold XTOC as of Q1 2026.

  • Barclays held 494 shares of Innovator US Equity Accelerated Plus ETF October worth $16K as of Q1 2026.
  • Barclays sold 300 Innovator US Equity Accelerated Plus ETF October shares in Q1 2026, an estimated $10K.
  • Innovator US Equity Accelerated Plus ETF October made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4620 holding.
  • Barclays first reported a position in Innovator US Equity Accelerated Plus ETF October in Q3 2024 and has held it in 7 quarters since.
  • Barclays's Innovator US Equity Accelerated Plus ETF October position peaked at $149K in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Innovator US Equity Accelerated Plus ETF October as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.